[{"AccountsPayableCurrent_0_Q1_USD":16239000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q1_USD":-7543000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q1_USD":-169000.0,"MarketableSecuritiesCurrent_0_Q1_USD":215642000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":4214000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":26667000.0,"SecuredLongTermDebt_0_Q1_USD":147569000.0,"InterestExpenseDebtExcludingAmortization_1_Q1_USD":3585000.0,"WarrantsAndRightsOutstanding_0_Q1_USD":12387000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":12596000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":23000000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q1_USD":6981000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":231000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":2662000.0,"InventoryValuationReserves_0_Q1_USD":200000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":4609000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":6077000.0,"InvestmentIncomeInterest_1_Q1_USD":1515000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1764000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":66722000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":3987000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-84961000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":60525000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2238346000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":12596000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":125893000.0,"ProceedsFromWarrantExercises_1_Q1_USD":0.0,"AssetsFairValueDisclosure_0_Q1_USD":218619000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":161000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":12088000.0,"PaymentsForTenantImprovements_1_Q1_USD":254000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1_Q1_USD":-56000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_1_Q1_USD":1536000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":4196000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-209000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":32501000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":52522000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":7503000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":2900000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":5322000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":190000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":21000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-4265000.0,"DeferredCreditsAndOtherLiabilitiesNoncurrent_0_Q1_USD":8906000.0,"DeferredCreditsAndOtherLiabilitiesCurrent_0_Q1_USD":1250000.0,"DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_0_Q1_USD":3055000.0,"DebtSecuritiesRealizedGainLoss_1_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":99500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-20448000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":123231000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":23612000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":215642000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":215613000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q1_USD":-931000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":106140000.0,"OtherAssetsNoncurrent_0_Q1_USD":29414000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":23612000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":15690000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":806000.0,"NetIncomeLoss_1_Q1_USD":-88948000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-107942000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":93246000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-1487000.0,"LiabilitiesCurrent_0_Q1_USD":91714000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":738349000.0,"Liabilities_0_Q1_USD":335755000.0,"InventoryNet_0_Q1_USD":12831000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-4016000.0,"ProfitLoss_1_Q1_USD":-88948000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":8358000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-88587000.0,"GrossProfit_1_Q1_USD":53973000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.35,"CommonStockValue_0_Q1_USD":2607000.0,"CommonStockSharesOutstanding_0_Q1_shares":257449955.0,"CommonStockSharesIssued_0_Q1_shares":257449955.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":123231000.0,"AssetsCurrent_0_Q1_USD":407949000.0,"Assets_0_Q1_USD":738349000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":29664000.0,"AccountsReceivableNetCurrent_0_Q1_USD":40555000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":361000.0,"Goodwill_0_Q1_USD":197797000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":47688000.0,"StockholdersEquity_0_Q1_USD":402594000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":6552000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":589000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":23612000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":931000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-8316000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":206000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q1_USD":0.0,"IncreaseDecreaseInInventories_1_Q1_USD":251000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-35251000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":5051000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":19260000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1857558000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":6077000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":40215000.0,"OperatingIncomeLoss_1_Q1_USD":-78057000.0,"OperatingExpenses_1_Q1_USD":132030000.0,"InterestPaidNet_1_Q1_USD":3693000.0,"InterestExpense_1_Q1_USD":3729000.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":2167000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":100000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":256968248.0,"ShareBasedCompensation_1_Q1_USD":12596000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":89120000.0,"Ticker":"FOLD","CIK":"1178879","name":"AMICUS THERAPEUTICS, INC.","OfficialName":"Amicus Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2296240629.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]